Rama K Mishra

USPTO Granted Patents = 16 (Patent Applications = 12)

CIPO Patents = 2

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 5.2

ph-index = 4

Forward Citations = 47(Granted Patents)

Company Filing History:

8 out of 26

Angion Biomedica Corporation

patents

6 out of 2,112

Northwestern University

patents

1 out of 1

Decode Genectics Ehf.

Years Active: 2008-2024

Loading Chart...

16 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12152007 - Substituted heterocycles as c-MYC targeting agents (2024-11-26),

2. 11504359 - Antifibrotic compounds and uses thereof (2022-11-22),

3. 11453640 - Small molecules for disrupting the super elongation complex and inhibiting transcription elongation for cancer therapy (2022-09-27),

4. 11142504 - Substituted heterocycles as c-MYC targeting agents (2021-10-12),

5. 10851082 - Substituted aromatic n-heterocyclic compounds as inhibitors of mitogen-activated protein kinase interacting kinase 1 (MNK1) and 2 (MNK2) (2020-12-01),

6. 10435375 - CXCR4 chemokine receptor modulators (2019-10-08),

7. 10414760 - Cytochrome P450 inhibitors and uses thereof (2019-09-17),

8. 10195184 - Antifibrotic compounds and uses thereof (2019-02-05),

9. 10093668 - Substituted aromatic N-heterocyclic compounds as inhibitors of mitogen-activated protein kinase interacting kinase 1 (Mnk1) and 2 (Mnk2) (2018-10-09),

10. 9597321 - Antifibrotic compounds and uses thereof (2017-03-21),

11. 9040555 - Antifibrotic compounds and uses thereof (2015-05-26),

12. 8865752 - Cytochrome P450 inhibitors and uses thereof (2014-10-21),

13. 8598359 - Biaryl substituted heterocycle inhibitors of LTA4H for treating inflammation (2013-12-03),

14. 8513291 - Cytochrome P450 inhibitors and uses thereof (2013-08-20),

15. 7648978 - Small molecule modulators of cytokine activity (2010-01-19),

Title: Innovations and Contributions of Rama K Mishra

Introduction

Rama K Mishra is a prominent inventor based in Chicago, IL, known for his significant contributions to the field of pharmaceuticals and therapeutics. With a total of 16 patents to his name, he has made remarkable strides in developing compounds that target critical health issues, particularly in cancer treatment and fibrosis.

Latest Patents

Among his latest patents, one notable invention is titled "Substituted heterocycles as c-MYC targeting agents." This patent discloses substituted heterocycle compounds, including substituted pyrazoles, substituted pyrimidines, and substituted triazoles. These compounds have shown potential in inhibiting c-MYC, making them valuable for therapeutic applications in treating cancer and cell proliferative disorders. Another significant patent is "Antifibrotic compounds and uses thereof," which provides compounds with a general structural formula and their pharmaceutically acceptable derivatives. This invention outlines pharmaceutical compositions and methods for treating conditions involving abnormal or excessive fibrosis.

Career Highlights

Rama K Mishra has worked with notable organizations such as Angion Biomedica Corporation and Northwestern University. His experience in these institutions has allowed him to collaborate on various innovative projects and contribute to advancements in medical research.

Collaborations

Some of his coworkers include Bijoy Panicker and Dong Sung Lim, who have worked alongside him in various research endeavors. Their collaboration has further enhanced the impact of his inventions in the scientific community.

Conclusion

Rama K Mishra's work exemplifies the spirit of innovation in the field of pharmaceuticals. His patents reflect a commitment to addressing critical health challenges through scientific research and development. His contributions continue to influence the landscape of medical therapeutics.

This text is generated by artificial intelligence and may not be accurate.